Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Mar;91(3):1067–1078. doi: 10.1172/JCI116264

Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.

R Bacchetta 1, B A Vandekerckhove 1, J L Touraine 1, M Bigler 1, S Martino 1, L Gebuhrer 1, J E de Vries 1, H Spits 1, M G Roncarolo 1
PMCID: PMC288061  PMID: 8450037

Abstract

We have studied the peripheral T cell repertoire of two patients with severe combined immunodeficiency who were successfully treated with human histocompatibility leukocyte antigen (HLA)-mismatched fetal liver stem cell transplantation. The patients presented a split chimerism. T cells were of donor origin, whereas the B cells/monocytes were of the host phenotype. Interestingly, the natural killer (NK) cells in one patient were donor derived and in the other patient of host origin. The NK cells were functional but did not have antihost or donor reactivity. Despite the HLA mismatch between donor and host cells, complete tolerance was achieved in vivo, and a specific unresponsiveness of peripheral blood mononuclear cells from both patients toward the host cells was demonstrated in vitro. Nevertheless, we could isolate T cell receptor (TCR)alpha beta, CD4+ or CD8+, T cell clones specifically reacting with HLA class I and II molecules of the host. The CD4+ host-reactive T cell clones from both patients produced interleukins 2 and 5, interferon-gamma, granulocyte/macrophage colony-stimulating factor but are specifically defective in interleukin 4 production. The frequencies of CD8+ host-reactive T cells were high, and were in the same range as those observed for CD8+ alloreactive T cells. In contrast, no donor-reactive CD8+ T cells or host or donor-reactive TCR gamma delta + T cells were detected. These data indicate that, after fetal stem cell transplantation, donor-reactive, but not host-reactive cells, are deleted from the T cell repertoire. Therefore, a peripheral mechanism of suppression or clonal anergy, rather than clonal deletion, is involved in maintaining in vivo tolerance toward the host.

Full text

PDF
1067

Images in this article

1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1069Image
on p.1069
1071Image
on p.1071
1071Image
on p.1071
1071Image
on p.1071
1071Image
on p.1071
1071Image
on p.1071
1071Image
on p.1071
1071Image
on p.1071
1071Image
on p.1071
1073Image
on p.1073
1073Image
on p.1073

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J. S., Roncarolo M. G., Yssel H., Andersson U., Gleich G. J., Silver J. E. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev. 1992 Jun;127:5–24. doi: 10.1111/j.1600-065x.1992.tb01406.x. [DOI] [PubMed] [Google Scholar]
  2. Ault K. A., Antin J. H., Ginsburg D., Orkin S. H., Rappeport J. M., Keohan M. L., Martin P., Smith B. R. Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med. 1985 Jun 1;161(6):1483–1502. doi: 10.1084/jem.161.6.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bacchetta R., de Waal Malefijt R., Yssel H., Abrams J., de Vries J. E., Spits H., Roncarolo M. G. Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. J Immunol. 1990 Feb 1;144(3):902–908. [PubMed] [Google Scholar]
  4. Bensussan A., David V., Vilmer E., Leca G., Boumsell L. Immunodeficiency after bone marrow transplantation can be associated with autoreactive T-cell receptor gamma delta-bearing lymphocytes. Immunol Rev. 1990 Aug;116:5–13. doi: 10.1111/j.1600-065x.1990.tb00801.x. [DOI] [PubMed] [Google Scholar]
  5. Biassoni R., Ferrini S., Prigione I., Moretta A., Long E. O. CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene. J Immunol. 1988 Mar 1;140(5):1685–1689. [PubMed] [Google Scholar]
  6. Borst J., van de Griend R. J., van Oostveen J. W., Ang S. L., Melief C. J., Seidman J. G., Bolhuis R. L. A T-cell receptor gamma/CD3 complex found on cloned functional lymphocytes. Nature. 1987 Feb 19;325(6106):683–688. doi: 10.1038/325683a0. [DOI] [PubMed] [Google Scholar]
  7. Bottino C., Tambussi G., Ferrini S., Ciccone E., Varese P., Mingari M. C., Moretta L., Moretta A. Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor. J Exp Med. 1988 Aug 1;168(2):491–505. doi: 10.1084/jem.168.2.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Buckley R. H., Schiff S. E., Sampson H. A., Schiff R. I., Markert M. L., Knutsen A. P., Hershfield M. S., Huang A. T., Mickey G. H., Ward F. E. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol. 1986 Apr 1;136(7):2398–2407. [PubMed] [Google Scholar]
  9. Casorati G., De Libero G., Lanzavecchia A., Migone N. Molecular analysis of human gamma/delta+ clones from thymus and peripheral blood. J Exp Med. 1989 Nov 1;170(5):1521–1535. doi: 10.1084/jem.170.5.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dallman M. J., Shiho O., Page T. H., Wood K. J., Morris P. J. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med. 1991 Jan 1;173(1):79–87. doi: 10.1084/jem.173.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. De Villartay J. P., Griscelli C., Fischer A. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation. Eur J Immunol. 1986 Feb;16(2):117–122. doi: 10.1002/eji.1830160202. [DOI] [PubMed] [Google Scholar]
  12. Dilloo D., Hanenberg H., Schneider E. M., Hauch M., Nürnberger W., Zimmer B. M., Vöhringer R., Wernet P., Göbel U., Burdach S. E. Treatment of donor T cell-mediated hematopoietic suppression after haploidentical bone marrow transplantation by T cell modulation in a patient with severe combined immunodeficiency. Bone Marrow Transplant. 1992 Jan;9(1):57–62. [PubMed] [Google Scholar]
  13. Drobyski W. R., Piaskowski V., Ash R. C., Casper J. T., Truitt R. L. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. Transplantation. 1990 Oct;50(4):625–632. doi: 10.1097/00007890-199010000-00020. [DOI] [PubMed] [Google Scholar]
  14. Essery G., Feldmann M., Lamb J. R. Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology. 1988 Jul;64(3):413–417. [PMC free article] [PubMed] [Google Scholar]
  15. Fischer A., Landais P., Friedrich W., Morgan G., Gerritsen B., Fasth A., Porta F., Griscelli C., Goldman S. F., Levinsky R. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet. 1990 Oct 6;336(8719):850–854. doi: 10.1016/0140-6736(90)92348-l. [DOI] [PubMed] [Google Scholar]
  16. Gaines A. D., Schiff S. E., Buckley R. H. Donor type natural killer cells after haploidentical T cell-depleted bone marrow stem cell transplantation in a patient with adenosine deaminase-deficient severe combined immunodeficiency. Clin Immunol Immunopathol. 1991 Aug;60(2):299–304. doi: 10.1016/0090-1229(91)90072-i. [DOI] [PubMed] [Google Scholar]
  17. Gebuhrer L., Lambert J., Labonne M. P., Mollet I., Freidel A. C., Betuel H. Alloantisera can detect some of the variants of HLA DRw13 identified by oligotyping. Tissue Antigens. 1992 Jan;39(1):42–47. doi: 10.1111/j.1399-0039.1992.tb02157.x. [DOI] [PubMed] [Google Scholar]
  18. Geha R. S., Rosen F. S. The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient. J Immunol. 1989 Jul 1;143(1):84–88. [PubMed] [Google Scholar]
  19. Harding F. A., McArthur J. G., Gross J. A., Raulet D. H., Allison J. P. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature. 1992 Apr 16;356(6370):607–609. doi: 10.1038/356607a0. [DOI] [PubMed] [Google Scholar]
  20. Keever C. A., Flomenberg N., Brochstein J., Sullivan M., Collins N. H., Burns J., Dupont B., O'Reilly R. J. Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Clin Immunol Immunopathol. 1988 Sep;48(3):261–276. doi: 10.1016/0090-1229(88)90020-7. [DOI] [PubMed] [Google Scholar]
  21. Keever C. A., Flomenberg N., Gazzola M. V., Pekle K., Yang S. Y., Small T. N., Collins N. H., O'Reilly R. J. Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease. Hum Immunol. 1990 Sep;29(1):42–55. doi: 10.1016/0198-8859(90)90068-z. [DOI] [PubMed] [Google Scholar]
  22. Lanier L. L., Spits H., Phillips J. H. The developmental relationship between NK cells and T cells. Immunol Today. 1992 Oct;13(10):392–395. doi: 10.1016/0167-5699(92)90087-N. [DOI] [PubMed] [Google Scholar]
  23. Miyawaki T., Kasahara Y., Taga K., Yachie A., Taniguchi N. Differential expression of CD45RO (UCHL1) and its functional relevance in two subpopulations of circulating TCR-gamma/delta+ lymphocytes. J Exp Med. 1990 May 1;171(5):1833–1838. doi: 10.1084/jem.171.5.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Murphy W. J., Kumar V., Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med. 1987 Apr 1;165(4):1212–1217. doi: 10.1084/jem.165.4.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nagler A., Lanier L. L., Cwirla S., Phillips J. H. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol. 1989 Nov 15;143(10):3183–3191. [PubMed] [Google Scholar]
  26. O'Reilly R. J., Keever C. A., Small T. N., Brochstein J. The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodefic Rev. 1989;1(4):273–309. [PubMed] [Google Scholar]
  27. Paliard X., de Waal Malefijt R., Yssel H., Blanchard D., Chrétien I., Abrams J., de Vries J., Spits H. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J Immunol. 1988 Aug 1;141(3):849–855. [PubMed] [Google Scholar]
  28. Parker C. M., Groh V., Band H., Porcelli S. A., Morita C., Fabbi M., Glass D., Strominger J. L., Brenner M. B. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med. 1990 May 1;171(5):1597–1612. doi: 10.1084/jem.171.5.1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Parkman R. The biology of bone marrow transplantation for severe combined immune deficiency. Adv Immunol. 1991;49:381–410. doi: 10.1016/s0065-2776(08)60780-4. [DOI] [PubMed] [Google Scholar]
  30. Pessano S., Oettgen H., Bhan A. K., Terhorst C. The T3/T cell receptor complex: antigenic distinction between the two 20-kd T3 (T3-delta and T3-epsilon) subunits. EMBO J. 1985 Feb;4(2):337–344. doi: 10.1002/j.1460-2075.1985.tb03634.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Peter H. H., Friedrich W., Dopfer R., Müller W., Kortmann C., Pichler W. J., Heinz F., Rieger C. H. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients. J Immunol. 1983 Nov;131(5):2332–2339. [PubMed] [Google Scholar]
  32. Phillips J. H., Hori T., Nagler A., Bhat N., Spits H., Lanier L. L. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. J Exp Med. 1992 Apr 1;175(4):1055–1066. doi: 10.1084/jem.175.4.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Robertson M. J., Ritz J. Biology and clinical relevance of human natural killer cells. Blood. 1990 Dec 15;76(12):2421–2438. [PubMed] [Google Scholar]
  34. Roncarolo M. G., Bigler M., Haanen J. B., Yssel H., Bacchetta R., de Vries J. E., Spits H. Natural killer cell clones can efficiently process and present protein antigens. J Immunol. 1991 Aug 1;147(3):781–787. [PubMed] [Google Scholar]
  35. Roncarolo M. G., Touraine J. L., Banchereau J. Cooperation between major histocompatibility complex mismatched mononuclear cells from a human chimera in the production of antigen-specific antibody. J Clin Invest. 1986 Mar;77(3):673–680. doi: 10.1172/JCI112361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Roncarolo M. G., Yssel H., Touraine J. L., Bacchetta R., Gebuhrer L., De Vries J. E., Spits H. Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J Exp Med. 1988 Dec 1;168(6):2139–2152. doi: 10.1084/jem.168.6.2139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Roncarolo M. G., Yssel H., Touraine J. L., Betuel H., De Vries J. E., Spits H. Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera. J Exp Med. 1988 May 1;167(5):1523–1534. doi: 10.1084/jem.167.5.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Schiff S. E., Buckley R. H. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras. J Immunol. 1987 Apr 1;138(7):2088–2094. [PubMed] [Google Scholar]
  39. Schwartz R. H. A cell culture model for T lymphocyte clonal anergy. Science. 1990 Jun 15;248(4961):1349–1356. doi: 10.1126/science.2113314. [DOI] [PubMed] [Google Scholar]
  40. Spits H., Touraine J. L., Yssel H., de Vries J. E., Roncarolo M. G. Presence of host-reactive and MHC-restricted T cells in a transplanted severe combined immunodeficient (SCID) patient suggest positive selection and absence of clonal deletion. Immunol Rev. 1990 Aug;116:101–116. doi: 10.1111/j.1600-065x.1990.tb00806.x. [DOI] [PubMed] [Google Scholar]
  41. Spits H., Yssel H., Takebe Y., Arai N., Yokota T., Lee F., Arai K., Banchereau J., de Vries J. E. Recombinant interleukin 4 promotes the growth of human T cells. J Immunol. 1987 Aug 15;139(4):1142–1147. [PubMed] [Google Scholar]
  42. Tilkin A. F., Vinci G., Michon J., Levy J. P. Autoreactive HLA-DR-specific autoreactive T-cell clones: possible regulatory function for B lymphocytes and hematopoietic precursors. Immunol Rev. 1990 Aug;116:171–181. doi: 10.1111/j.1600-065x.1990.tb00810.x. [DOI] [PubMed] [Google Scholar]
  43. Touraine J. L., Bétuel H. Immunodeficiency diseases and expression of HLA antigens. Hum Immunol. 1981 Mar;2(2):147–153. doi: 10.1016/0198-8859(81)90061-6. [DOI] [PubMed] [Google Scholar]
  44. Touraine J. L., Roncarolo M. G., Royo C., Touraine F. Fetal tissue transplantation, bone marrow transplantation and prospective gene therapy in severe immunodeficiencies and enzyme deficiencies. Thymus. 1987;10(1-2):75–87. doi: 10.1007/978-94-009-3365-1_8. [DOI] [PubMed] [Google Scholar]
  45. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187–376. doi: 10.1016/S0065-2776(08)60664-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Vandekerckhove B. A., Namikawa R., Bacchetta R., Roncarolo M. G. Human hematopoietic cells and thymic epithelial cells induce tolerance via different mechanisms in the SCID-hu mouse thymus. J Exp Med. 1992 Apr 1;175(4):1033–1043. doi: 10.1084/jem.175.4.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wijnaendts L., Le Deist F., Griscelli C., Fischer A. Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency. Blood. 1989 Nov 1;74(6):2212–2219. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES